Clinical Trial Update: Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ex-vivo primed memory donor lymphocyte infusion to boost antiviral immunity after T-cell depleted hematopoietic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Relapse
• Acute Myeloid Leukemia
• Biphenotypic Leukemia in Relapse
• High Risk Acute Lymphoblastic Leukemia
• High Risk Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN